MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-22-0072398
NGB Laboratories Private Limited - pharma in Surat, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.72 Cr
▲ 5% YoY
Net profit · FY 2025
₹10.09 Lakh
Net margin 5.9%
EBITDA · FY 2025
₹10.12 Lakh
EBITDA margin 5.9%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹11.75 Cr
Issued & subscribed
Satisfied charges
₹31.7 Cr
No open charges
Company age
12 yrs
Est. 2014
Employees · EPFO
3
Provident fund records
About NGB Laboratories Private Limited
Data last updated:
NGB Laboratories Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2014PTC078771. Its GSTIN is 24AAECN6047R1ZX (Gujarat).
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹11.75 Cr. It is led by directors including Harishkumar Natverlal Bachkaniwala and Manishkumar Harishkumar Bachkaniwala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 31 Prajit Row House B/H. Nehru Nagar Umra Athwalines, Surat, Gujarat, India – 395007.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.72 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹10.09 Lakh (net margin 5.9%) and EBITDA of ₹10.12 Lakh (EBITDA margin 5.9%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 19% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: NGB Laboratories. As per MCA filings, the company has satisfied charges of ₹31.7 Cr on record. The company has 5 deals on record (3 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹27.78 Cr; the latest was in March 2021. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 3 smaller; the largest is Aman Formulations Private Limited with revenue of ₹1.72 Cr.
NGB Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0072398). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ngblaboratories.com.
Company details
CIN U24100GJ2014PTC078771
Registration Number 078771
Incorporation Date 17 February 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-22-0072398
Key People
Harishkumar Natverlal Bachkaniwala Director Manishkumar Harishkumar Bachkaniwala Director Jasmin Mansukhlal Bachkaniwala Director Recognitions & Rankings of NGB Laboratories
Contact details
NGB Laboratories Private Limited's registered office is in Surat, Gujarat. Its website is ngblaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address31 Prajit Row House B/H. Nehru Nagar Umra Athwalines, Surat, Gujarat, India – 395007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of NGB Laboratories Private Limited, buy the company report.
Comprehensive company report
NGB Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
NGB Laboratories operates one associated brand: NGB Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| NGB Laboratories develops and manufactures a range of pharmaceutical products, including antibiotics. | ngblaboratories.com |
Business activity
The main business activity of NGB Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of NGB Laboratories Private Limited, buy the company report.
Financials of NGB Laboratories Private Limited
FY 2025 filings availableNGB Laboratories Private Limited reported revenue of ₹1.72 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹1.72 Cr ▲ 5%
Net profit · FY 2025
₹10.09 Lakh margin 5.9%
EBITDA · FY 2025
₹10.12 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▼ 47%
5 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▲ 312%
3 years · compounded
▲ 26%
5 years · compounded
▼ 1%
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 19%. EBITDA rose 312% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of NGB Laboratories Private Limited, buy the company report.
Board of directors of NGB Laboratories Private Limited
NGB Laboratories has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harishkumar Natverlal Bachkaniwala | Director | 17 Feb 2014 | 12 Years 8 Months | Current |
| Manishkumar Harishkumar Bachkaniwala | Director | 17 Feb 2014 | 12 Years 8 Months | Current |
| Jasmin Mansukhlal Bachkaniwala | Director | 19 Feb 2014 | 12 Years 8 Months | Current |
| Dharmesh Pravin Kharwar | Director | 04 Apr 2019 | 7 Years 6 Months | Current |
| Mansukhlal Natverlal Bachkaniwala | Director | 19 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
NGB Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aman Formulations Private Limited | ₹1.72 Cr (FY 2025) | -12.0% | Badaun, Uttar Pradesh, India | |||
| NGB Laboratories Private Limitedthis company | ₹1.72 Cr (FY 2025) | ₹10.09 Lakh | 5.9% | 5.0% | 3 | Surat, Gujarat, India |
| Canetis Healthcare Private Limited | ₹1.72 Cr (FY 2025) | 28.0% | Pune, Maharashtra, India | |||
| Zogenix Healthcare Private Limited | ₹1.71 Cr (FY 2024) | 27.0% | Hyderabad, Telangana, India | |||
| Ginics Healthcare Private Limited | ₹1.71 Cr (FY 2025) | 83.0% | Ottappalam, Kerala, India |
To see the full peer comparison of NGB Laboratories Private Limited, buy the company report.
Auditor
NGB Laboratories Private Limited is audited by A G H R & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A G H R & CO | FY 2022 | 138302W |
Shareholding
The shareholding of NGB Laboratories Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of NGB Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹31.7 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2020 | 100353137 | Others | ₹1 Cr | Satisfied | |
| 20 Dec 2017 | 100149158 | Others | ₹8.25 Cr | Satisfied | |
| 03 Mar 2015 | 10556658 | The Sutex Co-Operative Bank Ltd | ₹2.35 Cr | Satisfied | |
| 03 Mar 2015 | 10556659 | The Sutex Co-Operative Bank Ltd | ₹1 Cr | Satisfied | |
| 23 Feb 2015 | 10556662 | Others | ₹19.1 Cr | Satisfied |
To see the full charge records of NGB Laboratories Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
NGB Laboratories Private Limited has 5 deals on record (3 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹27.78 Cr; the latest was in March 2021.
Total deals
5
Funding rounds
3
Rights issue
1
Secondary share transfer
1
Disclosed funding
₹27.78 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Vedanti Pharma, 3 individuals |
| Mar 2021 | Funding round | ₹23.8 Cr | Investors: Mansukhlal Bachkaniwala HUF, Vedanti Pharma, 2 individuals |
| Nov 2020 | Funding round | ₹2 Cr | Investors: Airtech Systems (lndia) Private Limited |
| Dec 2019 | Rights issue | ₹50 Lakh | Investors: an individual |
| Feb 2017 | Funding round | ₹1.98 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving NGB Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for NGB Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
NGB Laboratories Private Limited has a workforce of 3 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
3
Active EPFO establishments
1
Employee growth
50%
GST
NGB Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECN6047R1ZX | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of NGB Laboratories Private Limited, buy the company report.
Recent activity
NGB Laboratories Private Limited has 9 board changes on record since 2014: 5 appointments and 4 cessations. The latest: Abhishek Anil Aggarwal ceased to be Additional Director on 25 Sep 2021.
AGM
Ngb Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ngb Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 06 Jul 2020 via Charge ID 100353137 with Others was fully satisfied on 30 Mar 2022.
Charges
A charge registered on 20 Dec 2017 via Charge ID 100149158 with Others was fully satisfied on 30 Mar 2022.
Charges
A charge registered on 03 Mar 2015 via Charge ID 10556658 with The Sutex Co-Operative Bank Ltd was fully satisfied on 30 Mar 2022.
Charges
A charge registered on 23 Feb 2015 via Charge ID 10556662 with Others was fully satisfied on 30 Mar 2022.
Ceased
Abhishek Anil Aggarwal ceased to be Additional Director.
Ceased
Sumeet Vijay Aggarwal ceased to be Additional Director.
Ceased
Sunil Satpal Aggarwal ceased to be Additional Director.
Charges
A charge registered on 03 Mar 2015 via Charge ID 10556659 with The Sutex Co-Operative Bank Ltd was fully satisfied on 31 Jul 2020.
Charges
A charge with Others of Rs. 19.10 Cr registered on 23 Feb 2015 with Charge ID 10556662 was modified on 09 Jul 2020.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100353137 was registered on 06 Jul 2020.
11 earlier events are in the company report.
Frequently asked questions
NGB Laboratories is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2014 (12+ years old) and is registered under CIN U24100GJ2014PTC078771.
NGB Laboratories has 5 current directors:
- Harishkumar Natverlal Bachkaniwala - Director
- Manishkumar Harishkumar Bachkaniwala - Director
- Jasmin Mansukhlal Bachkaniwala - Director
- Dharmesh Pravin Kharwar - Director
- Mansukhlal Natverlal Bachkaniwala - Director
The latest financial statements of NGB Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of NGB Laboratories is 24AAECN6047R1ZX, registered in Gujarat.
The CIN (Corporate Identification Number) of NGB Laboratories is U24100GJ2014PTC078771. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NGB Laboratories was incorporated on 17 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
NGB Laboratories has 5 deals on record (3 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹27.78 Cr; the latest was in March 2021.
The peers of NGB Laboratories by revenue are Aman Formulations Private Limited, Canetis Healthcare Private Limited, Zogenix Healthcare Private Limited, Ginics Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Abhishek Anil Aggarwal ceased to be Additional Director on 25 Sep 2021. Sumeet Vijay Aggarwal ceased to be Additional Director on 25 Sep 2021. Sunil Satpal Aggarwal ceased to be Additional Director on 25 Sep 2021. NGB Laboratories has 9 board changes on record in total.
Yes, NGB Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0072398).
NGB Laboratories can be reached through the website ngblaboratories.com. Its registered office is in Surat, Gujarat, India.